发明名称 |
GALENICAL FORMULATIONS OF ORGANIC COMPOUNDS |
摘要 |
The present invention relates to a pharmaceutical oral fixed dose combination comprising a) a therapeutically effective amount of Aliskiren, or a pharmaceutically acceptable salt thereof, b) a therapeutically effective amount of Valsartan, or a pharmaceutically acceptable salt thereof, wherein the pharmaceutical oral fixed dose combination shows an in vitro dissolution of component a) of 80% or less after 10 minutes and 98% or less after 20 minutes, and a dissolution profile of component b) of 25% or more after 30 minutes, and 40% or more after 60 minutes at pH 4.5.
|
申请公布号 |
US2010209480(A1) |
申请公布日期 |
2010.08.19 |
申请号 |
US20080678877 |
申请日期 |
2008.09.24 |
申请人 |
ALTENBURGER RALF;SAUNIER MAGGY B;BARGENDA NICOLE;BOCK MICHAEL A;ADLER SABINE;BUSS BRUNO;CURDY CATHERINE;GHOSH INDRAJIT;HIRSCH STEFAN;KELLER PATRICE F;KOCHHAR CHARU;LI SHOUFENG;LOGGIA NICOLETTA;MATHARU AMOL S;TAILLEMITE JULIEN;TONG WEI-QIN;VIPPAGUNTA SUDHA;WEN HONG;WOLF MARIE-CHRISTINE;LAKSHMAN JAY P;KOWALSKI JAMES |
发明人 |
ALTENBURGER RALF;SAUNIER MAGGY B.;BARGENDA NICOLE;BOCK MICHAEL A.;ADLER SABINE;BUSS BRUNO;CURDY CATHERINE;GHOSH INDRAJIT;HIRSCH STEFAN;KELLER PATRICE F.;KOCHHAR CHARU;LI SHOUFENG;LOGGIA NICOLETTA;MATHARU AMOL S.;TAILLEMITE JULIEN;TONG WEI-QIN;VIPPAGUNTA SUDHA;WEN HONG;WOLF MARIE-CHRISTINE;LAKSHMAN JAY P.;KOWALSKI JAMES |
分类号 |
A61K31/41;A61K9/14;A61K9/24;A61K9/48;A61K9/70;A61P9/04;A61P9/10;A61P9/12;A61P13/12;B29B9/06 |
主分类号 |
A61K31/41 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|